Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 26 | 2025 | 208 | 5.680 |
Why?
|
| Chemokine CX3CL1 | 10 | 2025 | 15 | 3.680 |
Why?
|
| Retina | 8 | 2025 | 289 | 2.560 |
Why?
|
| Receptors, Chemokine | 16 | 2016 | 72 | 2.560 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2023 | 131 | 1.800 |
Why?
|
| Diabetic Retinopathy | 3 | 2025 | 78 | 1.780 |
Why?
|
| Inflammation | 12 | 2025 | 758 | 1.740 |
Why?
|
| Mice | 40 | 2025 | 6644 | 1.430 |
Why?
|
| Mice, Transgenic | 14 | 2025 | 665 | 1.340 |
Why?
|
| Central Nervous System | 9 | 2024 | 152 | 1.190 |
Why?
|
| Disease Models, Animal | 15 | 2025 | 1596 | 1.180 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2025 | 75 | 1.140 |
Why?
|
| Animals | 48 | 2025 | 16992 | 1.120 |
Why?
|
| Neurocysticercosis | 5 | 2016 | 29 | 1.110 |
Why?
|
| Chemokines | 5 | 2016 | 96 | 1.050 |
Why?
|
| Mice, Inbred C57BL | 21 | 2025 | 1869 | 1.050 |
Why?
|
| Gliosis | 2 | 2024 | 25 | 0.990 |
Why?
|
| Myeloid Cells | 4 | 2013 | 31 | 0.920 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2016 | 55 | 0.880 |
Why?
|
| Demyelinating Diseases | 2 | 2022 | 14 | 0.850 |
Why?
|
| Brain | 10 | 2016 | 1472 | 0.830 |
Why?
|
| Ancrod | 1 | 2022 | 4 | 0.730 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 539 | 0.700 |
Why?
|
| Cell Separation | 3 | 2014 | 94 | 0.660 |
Why?
|
| Chemotaxis | 2 | 2013 | 68 | 0.650 |
Why?
|
| Interleukin-1beta | 2 | 2017 | 75 | 0.620 |
Why?
|
| Fibrinogen | 4 | 2023 | 24 | 0.610 |
Why?
|
| Flow Cytometry | 8 | 2015 | 411 | 0.590 |
Why?
|
| Astrocytes | 2 | 2024 | 244 | 0.590 |
Why?
|
| Signal Transduction | 7 | 2025 | 2157 | 0.580 |
Why?
|
| Leukocytes | 3 | 2018 | 80 | 0.570 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2003 | 17 | 0.540 |
Why?
|
| Central Nervous System Diseases | 2 | 2017 | 32 | 0.530 |
Why?
|
| Eosinophilia | 1 | 2016 | 17 | 0.500 |
Why?
|
| Cytokines | 9 | 2024 | 678 | 0.490 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2015 | 247 | 0.460 |
Why?
|
| Receptors, CCR2 | 3 | 2011 | 28 | 0.450 |
Why?
|
| Green Fluorescent Proteins | 3 | 2015 | 209 | 0.450 |
Why?
|
| Mice, Knockout | 10 | 2025 | 1035 | 0.450 |
Why?
|
| Neurons | 7 | 2018 | 1263 | 0.440 |
Why?
|
| Spinal Cord | 3 | 2013 | 114 | 0.430 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2014 | 1 | 0.420 |
Why?
|
| Receptors, HIV | 1 | 2013 | 5 | 0.410 |
Why?
|
| Receptors, Cytokine | 1 | 2013 | 11 | 0.410 |
Why?
|
| Autoimmunity | 2 | 2013 | 58 | 0.400 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 734 | 0.370 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 386 | 0.360 |
Why?
|
| Neurogenesis | 3 | 2018 | 63 | 0.350 |
Why?
|
| Gene Expression Regulation | 5 | 2025 | 1070 | 0.350 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 140 | 0.350 |
Why?
|
| Malaria, Cerebral | 2 | 2023 | 30 | 0.340 |
Why?
|
| Mesocestoides | 4 | 2013 | 23 | 0.340 |
Why?
|
| Embryonic Development | 1 | 2011 | 83 | 0.340 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 157 | 0.340 |
Why?
|
| Tauopathies | 3 | 2018 | 22 | 0.340 |
Why?
|
| Cytological Techniques | 1 | 2011 | 14 | 0.340 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2002 | 91 | 0.330 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 300 | 0.310 |
Why?
|
| Lipopolysaccharides | 4 | 2025 | 239 | 0.300 |
Why?
|
| Nervous System Diseases | 2 | 2007 | 77 | 0.300 |
Why?
|
| Lateral Ventricles | 2 | 2021 | 11 | 0.280 |
Why?
|
| Humans | 18 | 2025 | 43102 | 0.270 |
Why?
|
| Membrane Glycoproteins | 2 | 2022 | 224 | 0.260 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2006 | 38 | 0.240 |
Why?
|
| Oligodendroglia | 2 | 2021 | 27 | 0.240 |
Why?
|
| Cochlea | 1 | 2025 | 6 | 0.240 |
Why?
|
| Cells, Cultured | 7 | 2021 | 1621 | 0.230 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2025 | 10 | 0.230 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2025 | 7 | 0.230 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 11 | 0.230 |
Why?
|
| Organ Specificity | 2 | 2018 | 141 | 0.220 |
Why?
|
| Phagocytosis | 2 | 2024 | 86 | 0.220 |
Why?
|
| Meningoencephalitis | 1 | 2024 | 14 | 0.220 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2024 | 11 | 0.220 |
Why?
|
| Diphtheria Toxin | 1 | 2024 | 3 | 0.220 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 73 | 0.210 |
Why?
|
| tau Proteins | 3 | 2018 | 186 | 0.210 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2024 | 11 | 0.210 |
Why?
|
| Vimentin | 1 | 2024 | 44 | 0.210 |
Why?
|
| Cryptococcosis | 1 | 2024 | 43 | 0.210 |
Why?
|
| Immunologic Factors | 1 | 2024 | 51 | 0.200 |
Why?
|
| RNA | 1 | 2006 | 266 | 0.200 |
Why?
|
| Protein Isoforms | 1 | 2024 | 139 | 0.200 |
Why?
|
| Diabetes Complications | 1 | 2024 | 102 | 0.200 |
Why?
|
| Killer Cells, Natural | 2 | 2016 | 104 | 0.190 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 79 | 0.190 |
Why?
|
| Chemokines, CC | 1 | 2003 | 55 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 4 | 2016 | 694 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2024 | 171 | 0.190 |
Why?
|
| Cuprizone | 1 | 2022 | 5 | 0.190 |
Why?
|
| Myelin Sheath | 1 | 2022 | 46 | 0.180 |
Why?
|
| Homeostasis | 2 | 2014 | 192 | 0.180 |
Why?
|
| Macrophages | 2 | 2025 | 529 | 0.180 |
Why?
|
| Peptide Fragments | 2 | 2013 | 307 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2023 | 321 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 863 | 0.170 |
Why?
|
| Chemokine CCL2 | 3 | 2008 | 95 | 0.160 |
Why?
|
| Cell Movement | 6 | 2018 | 655 | 0.160 |
Why?
|
| Adaptive Immunity | 2 | 2024 | 34 | 0.150 |
Why?
|
| Ligands | 2 | 2013 | 388 | 0.150 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 934 | 0.150 |
Why?
|
| Chromatin | 2 | 2018 | 186 | 0.150 |
Why?
|
| Female | 10 | 2025 | 24698 | 0.150 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2018 | 1 | 0.140 |
Why?
|
| Male | 7 | 2025 | 23409 | 0.140 |
Why?
|
| Integrases | 1 | 2018 | 28 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 53 | 0.140 |
Why?
|
| Lymphocyte Activation | 3 | 2013 | 249 | 0.140 |
Why?
|
| Dendritic Cells | 3 | 2013 | 132 | 0.130 |
Why?
|
| Histones | 2 | 2018 | 197 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 518 | 0.120 |
Why?
|
| Mast Cells | 1 | 2016 | 82 | 0.120 |
Why?
|
| Neuroimmunomodulation | 1 | 2015 | 12 | 0.120 |
Why?
|
| Nitrites | 1 | 2015 | 55 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 384 | 0.120 |
Why?
|
| Neutrophils | 1 | 2016 | 145 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 183 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2015 | 77 | 0.110 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 12 | 0.110 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 1001 | 0.110 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2013 | 12 | 0.100 |
Why?
|
| Antigens | 1 | 2013 | 59 | 0.100 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2013 | 2 | 0.100 |
Why?
|
| Antigens, Ly | 1 | 2013 | 8 | 0.100 |
Why?
|
| Immunity | 1 | 2014 | 61 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2015 | 129 | 0.100 |
Why?
|
| Chimera | 1 | 2013 | 18 | 0.100 |
Why?
|
| Lymphoid Tissue | 1 | 2013 | 19 | 0.100 |
Why?
|
| Interleukin-1 | 1 | 2013 | 39 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2015 | 575 | 0.100 |
Why?
|
| Interleukin-17 | 1 | 2013 | 53 | 0.100 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2013 | 3 | 0.100 |
Why?
|
| Mannose-Binding Lectins | 1 | 2013 | 14 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 83 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 37 | 0.100 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 72 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 2 | 2018 | 81 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2015 | 386 | 0.090 |
Why?
|
| Aging | 1 | 2018 | 783 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 146 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2013 | 269 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2013 | 346 | 0.090 |
Why?
|
| Macrophage Activation | 2 | 2015 | 61 | 0.090 |
Why?
|
| Blood-Brain Barrier | 3 | 2008 | 173 | 0.090 |
Why?
|
| Genes, T-Cell Receptor delta | 2 | 2002 | 5 | 0.090 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 21 | 0.090 |
Why?
|
| Phagocytes | 1 | 2010 | 7 | 0.080 |
Why?
|
| Maze Learning | 3 | 2018 | 113 | 0.080 |
Why?
|
| Th1 Cells | 2 | 2002 | 97 | 0.080 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2010 | 95 | 0.080 |
Why?
|
| Gene Expression | 2 | 2021 | 701 | 0.080 |
Why?
|
| Microscopy, Confocal | 3 | 2021 | 224 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2010 | 104 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1455 | 0.080 |
Why?
|
| Stem Cells | 1 | 2010 | 152 | 0.080 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 53 | 0.070 |
Why?
|
| Chemokine CXCL2 | 1 | 2008 | 12 | 0.070 |
Why?
|
| Chemokine CXCL1 | 1 | 2008 | 18 | 0.070 |
Why?
|
| Chemokine CXCL10 | 1 | 2008 | 38 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2008 | 141 | 0.070 |
Why?
|
| Neuritis, Autoimmune, Experimental | 1 | 2007 | 1 | 0.060 |
Why?
|
| Chemokines, CX3C | 1 | 2007 | 1 | 0.060 |
Why?
|
| Chemotactic Factors | 1 | 2007 | 8 | 0.060 |
Why?
|
| Nervous System | 1 | 2007 | 32 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 25 | 0.060 |
Why?
|
| Motor Neuron Disease | 1 | 2006 | 2 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2021 | 638 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 65 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 719 | 0.060 |
Why?
|
| Cell Death | 1 | 2006 | 278 | 0.060 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2024 | 6 | 0.050 |
Why?
|
| Cryptococcus | 1 | 2024 | 10 | 0.050 |
Why?
|
| Monocytes | 1 | 2007 | 277 | 0.050 |
Why?
|
| Hydroxyurea | 1 | 2024 | 34 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2006 | 210 | 0.050 |
Why?
|
| Fibrin | 1 | 2023 | 10 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 386 | 0.050 |
Why?
|
| Chemokine CCL3 | 1 | 2003 | 14 | 0.050 |
Why?
|
| Chemokine CCL4 | 1 | 2003 | 19 | 0.050 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2003 | 16 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2007 | 561 | 0.050 |
Why?
|
| Leukopenia | 1 | 2002 | 10 | 0.050 |
Why?
|
| Leishmania donovani | 1 | 2001 | 18 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2021 | 11 | 0.040 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2001 | 17 | 0.040 |
Why?
|
| Spleen | 1 | 2001 | 204 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 456 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2015 | 986 | 0.040 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 1999 | 3 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 46 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2018 | 22 | 0.040 |
Why?
|
| Plasmodium chabaudi | 1 | 2018 | 1 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 1857 | 0.040 |
Why?
|
| Ammonia | 1 | 2018 | 22 | 0.040 |
Why?
|
| Larva | 1 | 1999 | 133 | 0.040 |
Why?
|
| Heparin | 1 | 2018 | 40 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2018 | 36 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 31 | 0.030 |
Why?
|
| Antibodies | 1 | 2018 | 144 | 0.030 |
Why?
|
| S Phase | 1 | 2018 | 36 | 0.030 |
Why?
|
| Methylation | 1 | 2018 | 119 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2018 | 87 | 0.030 |
Why?
|
| Lysine | 1 | 2018 | 119 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2018 | 122 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 243 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2015 | 14 | 0.030 |
Why?
|
| Psychomotor Disorders | 1 | 2015 | 9 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2015 | 29 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2015 | 15 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 78 | 0.030 |
Why?
|
| Liver | 1 | 2018 | 511 | 0.030 |
Why?
|
| Papio anubis | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2013 | 8 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2013 | 14 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 36 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 150 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2013 | 25 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2013 | 60 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 26 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 114 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 173 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2013 | 58 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2013 | 58 | 0.030 |
Why?
|
| Immunization | 1 | 2013 | 94 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 1177 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 94 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2013 | 117 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 368 | 0.020 |
Why?
|
| Hippocampus | 1 | 2015 | 594 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 291 | 0.020 |
Why?
|
| Silver Staining | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 49 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 22 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 113 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 68 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 109 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 145 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 105 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 65 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 127 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 142 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 139 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 352 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 652 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 458 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 780 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 712 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 7 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2005 | 18 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2005 | 48 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 30 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 259 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 306 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 526 | 0.010 |
Why?
|
| Mesocricetus | 1 | 2001 | 56 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2001 | 74 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 241 | 0.010 |
Why?
|